Masutomi K - Search Results

1

Khurts S, Masutomi K, Delgermaa L, Arai K, Oishi N, Mizuno H, Hayashi N, Hahn WC, Murakami S. Khurts S, et al. Among authors: masutomi k. J Biol Chem. 2004 Dec 3;279(49):51508-15. doi: 10.1074/jbc.M407643200. Epub 2004 Sep 14. J Biol Chem. 2004. PMID: 15371412 Free article.

2

Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component.

Masutomi K, Kaneko S, Hayashi N, Yamashita T, Shirota Y, Kobayashi K, Murakami S. Masutomi K, et al. J Biol Chem. 2000 Jul 21;275(29):22568-73. doi: 10.1074/jbc.M000622200. J Biol Chem. 2000. PMID: 10811633 Free article.

3

Two independent regions of human telomerase reverse transcriptase are important for its oligomerization and telomerase activity.

Arai K, Masutomi K, Khurts S, Kaneko S, Kobayashi K, Murakami S. Arai K, et al. Among authors: masutomi k. J Biol Chem. 2002 Mar 8;277(10):8538-44. doi: 10.1074/jbc.M111068200. Epub 2001 Dec 18. J Biol Chem. 2002. PMID: 11751869 Free article.

4

Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma.

Masutomi K, Kaneko S, Yasukawa M, Arai K, Murakami S, Kobayashi K. Masutomi K, et al. Oncogene. 2002 Aug 29;21(38):5946-50. doi: 10.1038/sj.onc.1205788. Oncogene. 2002. PMID: 12185596

5

Telomerase and tumorigenesis.

Masutomi K, Hahn WC. Masutomi K, et al. Cancer Lett. 2003 May 15;194(2):163-72. doi: 10.1016/s0304-3835(02)00703-6. Cancer Lett. 2003. PMID: 12757974 Review.

6

Telomerase maintains telomere structure in normal human cells.

Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC. Masutomi K, et al. Cell. 2003 Jul 25;114(2):241-53. doi: 10.1016/s0092-8674(03)00550-6. Cell. 2003. PMID: 12887925 Free article.

7

Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase.

Kyo S, Masutomi K, Maida Y, Kanaya T, Yatabe N, Nakamura M, Tanaka M, Takarada M, Sugawara I, Murakami S, Taira T, Inoue M. Kyo S, et al. Among authors: masutomi k. Am J Pathol. 2003 Sep;163(3):859-67. doi: 10.1016/S0002-9440(10)63446-3. Am J Pathol. 2003. PMID: 12937127 Free PMC article.

8

Telomerase expression--only half the story.

Masutomi K, Hahn WC. Masutomi K, et al. Cancer Biol Ther. 2003 Nov-Dec;2(6):685-6. Cancer Biol Ther. 2003. PMID: 14688477 No abstract available.

9

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen DY, Stephans KF, Masutomi K, Loda M, Xia Z, Anderson KS, Hahn WC, Nadler LM. Vonderheide RH, et al. Among authors: masutomi k. Clin Cancer Res. 2004 Feb 1;10(3):828-39. doi: 10.1158/1078-0432.ccr-0620-3. Clin Cancer Res. 2004. PMID: 14871958 Clinical Trial.

10

Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling.

Satyanarayana A, Greenberg RA, Schaetzlein S, Buer J, Masutomi K, Hahn WC, Zimmermann S, Martens U, Manns MP, Rudolph KL. Satyanarayana A, et al. Among authors: masutomi k. Mol Cell Biol. 2004 Jun;24(12):5459-74. doi: 10.1128/MCB.24.12.5459-5474.2004. Mol Cell Biol. 2004. PMID: 15169907 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page